Cocrystal Pharma, Inc. (NASDAQ:COCP) Short Interest Update

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 8,000 shares, a growth of 300.0% from the October 31st total of 2,000 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 18,100 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright decreased their price objective on shares of Cocrystal Pharma from $10.00 to $7.00 and set a “buy” rating for the company in a research report on Thursday, August 22nd.

Cocrystal Pharma Stock Performance

Shares of COCP stock traded down $0.02 on Thursday, reaching $2.10. 6,034 shares of the company were exchanged, compared to its average volume of 21,091. The company has a market cap of $21.36 million, a price-to-earnings ratio of -1.14 and a beta of 1.45. The business has a 50-day moving average price of $1.88 and a 200 day moving average price of $2.03. Cocrystal Pharma has a 1 year low of $1.33 and a 1 year high of $3.10.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.